How to Buy Bausch Health Companies Stock
Bausch Health Companies Inc
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology.
Bausch Health Companies stock last closed at $8.22, down 2.03% from the previous day, and has increased 14.97% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.29 percentage points. Bausch Health Companies stock is currently +47.58% from its 52-week low of $5.57, and -19.65% from its 52-week high of $10.23.
As of Sep 22, 2023, there are 364.33M shares of BHC outstanding. The market value of BHC is $2.99B. In the last 24 hours, 4.34M BHC shares were traded.
How to Buy Bausch Health Companies Stock
Wondering how to invest in Bausch Health Companies stock? Here's how.
- Choose where to buy Bausch Health Companies stock: You need to decide on a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you decide where to buy Bausch Health Companies stock.
- Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Fund your investment account: Pick your payment method and add your details.
- Analyze Bausch Health Companies stock: The Bausch Health Companies ticker symbol is BHC. Is Bausch Health Companies stock a good investment? Should you buy shares of BHC? How do BHC's underlying business fundamentals look? Do top analysts think Bausch Health Companies is a good buy? Why has BHC's stock price moved recently? (Hint: Our stock analysis website can help you decide if BHC is a good stock to buy).
- Place your BHC trade: Decide if you will purchase BHC shares at the current market price or use a limit order to buy BHC stock at a specific price.
- Get notifications regarding your BHC position: Create a watchlist to get live updates on your position in Bausch Health Companies stock.
Step 1: Choose where to buy Bausch Health Companies stock
You will need a brokerage account in order to access the NYSE market and buy BHC stock.
Our preferred brokerage: eToro
In our opinion, eToro is the best stock brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global financial markets: From Technology to Industrials, New York to Hong Kong — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by opening an account with eToro now.
Open eToro AccountStep 2: Create a brokerage account
Now that you've selected the best brokerage, it's time to fill out some personal information so you can buy BHC today.
How to Create a New Account on eToro
- Click here to get started.
- Enter your personal info to open a new brokerage account.
- Submit your details by hitting the "Create Account" button.
Step 3: Fund your investment account
Now that you have opened your account on a mobile trading app, you need to deposit funds:
Check out the walkthrough below for more details transferring funds into your new investment account.
Step 4: Analyze Bausch Health Companies stock
After you have figured out the best place to buy Bausch Health Companies stock, it's critical to analyze their stock before you buy, so you truly understand the risk as well as the upside.
Bausch Health Companies quick stats
BHC Due Diligence Checks
WallStreetZen was designed to help part-time investors perform better fundamental analysis.
You can see all of the due diligence checks on BHC's stock page.
How is BHC stock valued?
Analysts use many financial metrics, analyses, models, and charts to gauge BHC's fair value.
You can do additional valuation analysis on BHC's stock here.
BHC Financials at a glance
Passed Financial Due Diligence Checks:
- BHC has $588.00M in cash and short term investments. This is sufficient to cover its annual cash burn of $665.00M.
- There are more short-term assets than short-term liabilities on the BHC balance sheet.
Failed Financial Due Diligence Checks:
- Total BHC debt is still negative.
- There are more long-term liabilities than short-term assets on the BHC balance sheet.
- BHC debt to equity ratio of -38.06 is negative.
- BHC profit margin has gone down from 0.5% to -2.2% in the past year.
- BHC has cash burn of 665000000. It does not have sufficient cash and short-term investments to cover this.
Do Wall Street analysts think it's a good time to buy BHC stock
Out of 2 Wall Street analysts who monitor BHC, the consensus analyst rating on BHC is a Buy
Please note that analyst ratings are not recommendations, nor are they investment advice.
Most Recent BHC Analyst Recommendations
David Steinberg, a top 12% analyst from Jefferies upgrades BHC to a strong buy rating and raises their BHC price target from $9.00 to $16.00, on Sep 20, 2023.
Jefferies's David Steinberg upgraded their rating on Bausch Health Companies (NYSE: BHC) from Hold to Strong Buy on 2023/09/20. The analyst also raised their price target by 77.8% from $9 to $16.
Steinberg suggested Bausch Health "may have some legal victories in the Xifaxan litigation* with updates in Q4 2023 and Q1 2024."
Once all the legal issues are ironed out, "the path to the 80% Bausch & Lomb spin will become more defined," the analyst continued.
Steinberg added that "a positive Xifaxan catalyst increases the probability of the spin and accounts for their price target hike."
Footnotes
* From here: On July 28, 2022, Bausch provided an update on its Xifaxan patent dispute case against Norwich Pharmaceuticals Inc., in which the court ruled that certain Bausch patents were invalid.
From here: On 2023/05/17, Bausch and its gastroenterology business, Salix Pharmaceuticals, announced that the U.S. District Court of Delaware has denied Norwich Pharmaceuticals’ motion to modify the Court’s final judgment that prevents the U.S. FDA from approving Norwich’s ANDA (abbreviated new drug application) for XIFAXAN® (rifaximin) 550 mg before 2029/10/02. As a result of this decision, Norwich’s ANDA cannot be approved until 2029/10/02.
Douglas Miehm, a bottom 6% analyst from RBC Capital maintains BHC with a hold rating and lowers their BHC price target from $9.00 to $8.00, on May 5, 2023.
You can dig deeper into what analysts are saying on the Bausch Health Companies stock forecast page.
BHC Technicals
BHC Growth Numbers
Last year, BHC revenue was $8.35B. In the past five year, BHC's revenue has gone up by -0.37% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 24.89%.
Dig into BHC's earnings and revenue performance here.
Who is buying/selling BHC?
In the last 12 months, insiders at BHC have sold more shares than they have bought.
Seana Carson, EVP General Counsel of BHC, was the latest BHC insider to sell. They sold $55,351.80 worth of BHC stock on Sep 6, 2023.
Research more about who owns BHC shares here.
Can I rely on BHC as an income stream?
No, Bausch Health Companies doesn't provide an income stream by paying out dividends.
BHC Social Trading Data
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your BHC trade
You have two main options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually fine for most investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a particular dollar amount, place a limit order.
Click the Open button and your broker will place your order.
If you want more info about buying stocks on eToro, watch the helpful video below:
Step 6: Get notifications regarding your BHC position
Now that you own some BHC shares, you'll want to stay up-to-date on your investment.
Add BHC to a watchlist to track the latest developments regarding your BHC stock.
BHC Feed
How to Buy Stock in Bausch Health Companies
To reiterate, here are the 6 steps for buying Bausch Health Companies stock:
- Choose where to buy Bausch Health Companies stock
- Create a brokerage account
- Fund your investment account
- Analyze Bausch Health Companies stock
- Place your BHC trade
- Get notifications regarding your BHC position
If you are looking for a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get the latest scoop on your investment in Bausch Health Companies, add BHC to your watchlist below.
More "How To" Guides You May Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.